Scientists could develop a nasal spray to treat the most common genetic form of motor neurone disease (MND) and some types of dementia.
“World leading” British researchers believe they could be a step closer to halting the devastating death of nerve cells that leads to disability and death.
Early-stage studies by Sheffield University suggest using a small peptide could block mutant repeated strands of information from being used by the body to make toxic components that contribute to frontotemporal dementia.
